insights_auto
Why is 0QF up 5.13%?
Dive Deeperchevron_right
0QF:ETR
Moderna Inc
€246.80
arrow_upward
+5.13%(+12.05) 1D
Nov 9, 5:35:58 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
€227.95
High
€247.65
Low
€227.00
Mkt. cap
107.39B
Avg. vol.
36.74K
Volume
50.86K
52-wk high
€247.65
52-wk low
€19.37
No. of employees
5K
Open
€227.95
High
€247.65
Low
€227.00
Mkt. cap
107.39B
Avg. vol.
36.74K
Volume
50.86K
52-wk high
€247.65
52-wk low
€19.37
No. of employees
5K
News stories
From web sources and news partners
The Motley Fool
·
3 hours ago
Moderna's Q3 Numbers May Have Seemed Impressive, but They Aren't Enough to Make the Stock a Buy
Investing.com
·
8 hours ago
Piper Sandler raises Moderna stock price target on sales beat
Blockchain News
·
10 hours ago
MRNA Price Prediction: Moderna tests resistance as earnings strength clashes with heavy short bias
Yahoo Finance
·
14 hours ago
Zacks Investment Ideas feature highlights: Moderna, AbbVie, Eli Lilly and Merck
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc
CEOStéphane Bancel
Employees4.7K
FoundedSep 2010
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitemodernatx.com